Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the PATHFAST TB LAM Ag Assay as a Treatment Monitoring Tool for Pulmonary Tuberculosis: A Prospective Longitudinal Study in Nairobi, Kenya

NCT07157904 is registered in ClinicalTrials.gov with Nagasaki University as lead sponsor.

NCT NCT07157904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07157904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the PATHFAST TB LAM Ag Assay as a Treatment Monitoring Tool for Pulmonary Tuberculosis: A Prospective Longitudinal Study in Nairobi, Kenya
Lead sponsor
Nagasaki University
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
July 31, 2027
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mycobacterium tuberculosis, pulmonary tuberculoses, tuberculosis